Biotechnology Allogene Therapeutics Appoints Scientific Pioneer Stephen Mayo to its Board of Directors July 12, 2022
Biotechnology Leap Therapeutics Announces Initiation of New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endometrial Cancer July 12, 2022
Biotechnology BIO-TECHNE LAUNCHES NEW TURBO CE-SDS(TM) CARTRIDGE, ACCELERATING PROTEIN PURITY ANALYSIS THROUGHPUT BY 400% July 12, 2022
Biotechnology LAWSUITS FILED AGAINST AXSM, NOTV and OM – JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS July 11, 2022
Biotechnology AXSM FINAL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important July 12 Deadline in Securities Class Action – AXSM July 11, 2022
Biotechnology BioMarin Presents Findings from Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress July 9-12, Including 4 Oral and 2 Poster Presentations July 11, 2022
Biotechnology AXSM Final Deadline July 12: ROSEN, A TOP RANKED LAW FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – AXSM July 10, 2022
Biotechnology AXSM FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important July 12 Deadline in Securities Class Action – AXSM July 9, 2022
Search
biotech stocks
